Periodic monitoring Active

Key facts

  • In April 2026, 29 EU/EEA countries reported measles data. Seventeen countries reported 451 cases and 12 countries reported zero cases.
  • During the previous 12-month period, three deaths attributable to measles were reported to ECDC by France (2) and the Netherlands (1).
  • Overall, case numbers increased compared with the previous month.
  • Complementary epidemic intelligence surveillance was performed on 11 June 2026. Outbreaks have been reported in Bulgaria. Sporadic cases and clusters were reported in several EU/EEA countries. Updates are provided for several countries and regions outside the EU/EEA.

Overview

In April 2026, 29 EU/EEA countries reported measles data. Seventeen countries reported 451 cases and 12 countries reported zero cases.

Overall, case numbers increased compared with the previous month; however, this may be subject to change in the event of a future retrospective update. The highest case counts were reported by Bulgaria (163), Italy (133), Latvia (38), France (32) and Spain (23).

In the most recent 12-month period, from 1 May 2025 to 30 April 2026, 30 EU/EEA countries reported a total of 3 779 cases of measles, 3 161 (83.6%) of which were laboratory confirmed.

Of the 3 779 cases with known age, 1 267 (33.5%) were in children under five years old; 1 655 (43.8%) cases were in those aged 15 years old or above. The highest notification rates were observed among infants under one year old (112.9 cases per million) and children aged 1–4 years old (53.8 cases per million).

Of 3 266 individuals (86.4% of all cases) with known age and vaccination status, 2 551 (78.1%) were unvaccinated, 396 (12.1%) were vaccinated with one dose of a measles-containing vaccine, 283 (8.7%) were vaccinated with two or more doses, and 32 (1.0%) were vaccinated with an unknown number of doses.

During the 12-month period, three deaths attributable to measles were reported to ECDC by France (2) and the Netherlands (1). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.

Complementary epidemic intelligence surveillance was performed on 11 June 2026. Outbreaks continue in Bulgaria. Sporadic cases and clusters were reported in several EU/EEA countries. Updates are provided for several countries and regions outside the EU/EEA. Outside the EU/EEA, updates have been provided by England, Ukraine, Africa CDC, the World Health Organization Pan American Health Organization (WHO PAHO), Japan, Canada, the United States (US), and Mexico.

Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to EpiPulse Cases. Data presented in the two monthly reports may differ.

Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:

Austria reported seven confirmed or probable cases in 2026 and as of 10 June 2026.

Bulgaria is experiencing an ongoing outbreak, with 364 cases of measles reported from 1 January to 8 June 2026. The cases have been reported in nine districts, most of which are bordering Romania. Most of the cases are reported in the Vratsa region (198), as well as the Pleven (101) and Lovech (41) regions; cases have also been reported in the Sofia City (7), Varna (3), Vidin (1), Sofia (1) and Targovishte (1) regions. Most of the cases are in children under 10 years old (231/364), with highest incidence in those under one year old (73 cases per 100 000 population), followed by 1–4 years old (46 per 100 000 population), 5–9 years old (29 per 100 000 population), and 10–14 years old (16 per 100 000 population). From the 331 cases with known vaccination status, 187 cases were not vaccinated. Over 39 799 MMR vaccine doses have been administered in response to the outbreak. From January to December 2025, Bulgaria reported two cases.

Czechia reported four cases between 1 January and 1 June 2026.

Germany reported 95 confirmed and probable measles cases in 2026 (weeks 1 to 24), an increase of 13 cases from week 21.

Lithuania reported nine cases from 1 January to 5 June 2026.

The Netherlands reported eight measles cases in 2026 and as of 3 June. There is currently no indication of a national outbreak. Of the reported cases, four were imported from abroad (Indonesia, Iraq and Türkiye).

Norway reported one case of measles in 2026.

Poland reported 22 cases of measles from 1 January to 31 May 2026.

Portugal reported seven measles cases on 21 May 2026, in the Northern region, Lisbon Tagus Valley, Alentejo and Algarve.

Spain reported 129 cases of measles from 1 January to 7 June 2026, including 11 imported cases and 26 cases related to imported cases. This represents an increase of 11 cases since 17 May 2026.

Epidemiological summary for EU/EEA outermost territories with relevant epidemic intelligence updates:

No new outbreaks or cases have been detected in the reporting period.

Western Balkans countries and Türkiye

No new outbreaks or cases have been detected in the reporting period.

Epidemiological summary for selected countries outside of the EU/EEA with relevant epidemic intelligence updates:

England reported 736 confirmed measles cases, including two deaths, from 1 January to 8 June 2026. Between January and December 2025, England reported 959 confirmed measles cases.

Ukraine reported 201 cases from January to April 2026. From January to December 2025, Ukraine reported 1 502 measles cases.

Africa CDC reported on 24 May 2026 that, in 2026, there have been 4 475 confirmed and 109 199 suspected cases of measles, including 784 deaths from 21 African Union Member State countries. High risk of measles spread is listed for Senegal, and moderate risk in Burundi and Mozambique.

Japan is experiencing an increase of measles cases in 2026. With 523 cases reported in weeks 1–22, the number of cases exceeds the total reported in the whole year of 2025 (265). The largest number of cases (70) was reported in week 17. Of the reported cases, 49 were imported.

 

According to the WHO Pan American Health Organization (WHO PAHO) report published on 23 May 2026, 21 153 confirmed measles cases have been reported by 17 countries. Most of these cases were reported in Mexico (11 006), Guatemala (6 622), the US (1 978) and Canada (1 052). Due to the upcoming FIFA World Cup 2026, a more detailed overview is provided for the hosting countries: Canada, Mexico and the US.

FIFA World Cup 2026 hosting countries:

Canada reported 1 063 measles cases, including 982 confirmed cases, and no deaths across seven jurisdictions in 2026 and as of 30 May 2026. The country remains in active transmission across multiple provinces due to an ongoing multijurisdictional outbreak. The vast majority of the cases reported in 2026 are linked to this outbreak.

 

The US continues to face multiple concurrent outbreaks, including several that began in 2025 and have continued into 2026. Overall, the US Centers for Disease Control and Prevention (US CDC) reported 2 030 confirmed cases and no deaths between 1 January and 5 June 2026. In comparison, between January and December 2025, US CDC reported 2 288 cases of measles, including three deaths. There have been 30 new outbreaks reported in 2026 and 93% of confirmed cases are outbreak associated. The majority of the cases are in children (72%) and unvaccinated individuals (92%).

 

Mexico reported, on 9 June 2026, 11 569 confirmed cases and 14 deaths in 2026 only. Overall, since the beginning of the outbreak in 2025, 18 183 confirmed cases were reported, including 41 deaths. The number of cases is declining after a peak reported in week 6 in 2026. The most affected state in 2026 remains Jalisco (6 416 cases; three deaths).

For more information on the provisional number of cases outside the EU/EEA region, please visit the World Health Organization (WHO) website.

The numbers provided to WHO for EU/EEA countries are from EpiPulse Cases data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.

ECDC assessment

Although most recent cases were acquired through local or community transmission, travel-related cases continue to be reported.

Continued vigilance is essential due to sub-optimal vaccination coverage for measles-containing vaccines (MCV) in several EU/EEA countries, possible introduction from areas with ongoing transmission, and increased travel and population movement during holiday periods.

Actions

ECDC is monitoring the measles situation through its epidemic intelligence activities. Data collected via epidemic intelligence supplement the monthly outputs of measles surveillance data from EpiPulse Cases, which are routinely submitted by 30 EU/EEA countries.

ECDC urges EU/EEA public health authorities to focus on the following areas:

  • Close immunity gaps, achieve and maintain high vaccination coverage for measles-containing vaccines (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time, as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
  • Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
  • Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
  • Healthcare professionals should be fully vaccinated.
  • Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
  • Address barriers and engage with populations underserved by healthcare services. Systemic barriers that affect vaccine uptake in populations that are isolated and underserved by healthcare services need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
  • In light of the upcoming summer holiday season, travellers should check their vaccination status and consult their general practitioner to ensure they are up-to-date with recommended immunisations prior to departure.


ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.

Latest updates for this event

View all